Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary
Objective: Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This article provides an overview of efficacy and safety information for duloxetine 60 mg/day in the treatment of MDD, including its effect...
Saved in:
Main Authors: | Susan G Ball (Author), Durisala Desaiah (Author), Qi Zhang (Author), Michael E Thase (Author), David GS Perahia (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007) -
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004) -
Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis
by: P Ravindra Babu, et al.
Published: (2017) -
Continuation treatment of major depressive disorder: is there a case for duloxetine?
by: Trevor R Norman, et al.
Published: (2010) -
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
by: Melinda J. Gooderham, et al.
Published: (2023)